methyllycaconitine has been researched along with pk 11195 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Camarasa, J; Chipana, C; Escubedo, E; Pérez-Sánchez, M; Pubill, D | 1 |
1 other study(ies) available for methyllycaconitine and pk 11195
| Article | Year |
|---|---|
Methyllycaconitine prevents methamphetamine-induced effects in mouse striatum: involvement of alpha7 nicotinic receptors.
Topics: Aconitine; alpha7 Nicotinic Acetylcholine Receptor; Animals; Antioxidants; Blotting, Western; Body Temperature; Body Weight; Calcium; Cell Membrane; Central Nervous System Stimulants; Dopamine; Dopamine Plasma Membrane Transport Proteins; Enzyme Inhibitors; Immunohistochemistry; Isoquinolines; Male; Methamphetamine; Mice; Microglia; Motor Activity; Neostriatum; Neurotoxicity Syndromes; Nicotinic Antagonists; Radioligand Assay; Reactive Oxygen Species; Receptors, Nicotinic; Synaptic Vesicles; Synaptosomes; Tyrosine 3-Monooxygenase | 2005 |